Concepedia

Publication | Open Access

SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans

171

Citations

28

References

2011

Year

Abstract

The study is registered at ClinicalTrials.gov under identifier: NCT00740584.

References

YearCitations

Page 1